Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1α-XBP1 pathway
Crossref DOI link: https://doi.org/10.1631/jzus.B2100780
Published Online: 2022-05-20
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guo, Yuliang
Song, Siyu
Du, Xiaoxiao
Tian, Li
Zhang, Man
Zhou, Hongmin
Chen, Zhonghua Klaus
Chang, Sheng http://orcid.org/0000-0002-0820-0934
Text and Data Mining valid from 2022-05-01
Version of Record valid from 2022-05-01
Article History
Received: 11 September 2021
Accepted: 29 December 2021
First Online: 20 May 2022